NGAL-Siderocalin in kidney disease

  • Neal Paragas
  • , Andong Qiu
  • , Maria Hollmen
  • , Thomas L. Nickolas
  • , Prasad Devarajan
  • , Jonathan Barasch

Research output: Contribution to journalReview articlepeer-review

68 Scopus citations

Abstract

Kidney damage induces the expression of a myriad of proteins in the serum and in the urine. The function of these proteins in the sequence of damage and repair is now being studied in genetic models and by novel imaging techniques. One of the most intensely expressed proteins is lipocalin2, also called NGAL or Siderocalin. While this protein has been best studied by clinical scientists, only a few labs study its underlying metabolism and function in tissue damage. Structure-function studies, imaging studies and clinical studies have revealed that NGAL-Siderocalin is an endogenous antimicrobial with iron scavenging activity. This review discusses the "iron problem" of kidney damage, the tight linkage between kidney damage and NGAL-Siderocalin expression and the potential roles that NGAL-Siderocalin may serve in the defense of the urogenital system. This article is part of a Special Issue entitled: Cell Biology of Metals.

Original languageEnglish
Pages (from-to)1451-1458
Number of pages8
JournalBiochimica et Biophysica Acta - Molecular Cell Research
Volume1823
Issue number9
DOIs
StatePublished - Sep 2012

Keywords

  • Acute Kidney Injury
  • Catechol
  • Enterochelin
  • NGAL
  • Siderocalin
  • UTI

Fingerprint

Dive into the research topics of 'NGAL-Siderocalin in kidney disease'. Together they form a unique fingerprint.

Cite this